Acadian Asset Management LLC Has $8.20 Million Stock Position in iRadimed Corporation $IRMD

Key Points

• Acadian Asset Management LLC increased its holdings in iRadimed Corporation by 10.9% in the first quarter, now owning approximately 1.23% of the company valued at $8.2 million.
• iRadimed announced a quarterly dividend of $0.17 per share, resulting in an annualized dividend of $0.68 and a dividend yield of 1.0%.
• The stock performance shows a fifty-two week range with a low of $46.86 and a high of $74.43, and it opened at $71.27 recently.

Acadian Asset Management LLC grew its holdings in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) by 10.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 156,319 shares of the medical equipment provider's stock after purchasing an additional 15,329 shares during the period. Acadian Asset Management LLC owned approximately 1.23% of iRadimed worth $8,197,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. First Horizon Advisors Inc. increased its holdings in shares of iRadimed by 78.7% during the first quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock valued at $27,000 after purchasing an additional 226 shares during the period. US Bancorp DE increased its holdings in shares of iRadimed by 132.7% during the first quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider's stock valued at $75,000 after purchasing an additional 819 shares during the period. Quantbot Technologies LP acquired a new position in shares of iRadimed during the first quarter valued at $78,000. Comerica Bank increased its holdings in shares of iRadimed by 21.4% during the first quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider's stock valued at $120,000 after purchasing an additional 404 shares during the period. Finally, State of Wyoming acquired a new position in shares of iRadimed during the fourth quarter valued at $149,000. 92.34% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Monty K. Allen sold 1,102 shares of the firm's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total transaction of $76,148.20. Following the completion of the transaction, the director owned 19,898 shares of the company's stock, valued at $1,374,951.80. This trade represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 36.80% of the stock is owned by corporate insiders.

iRadimed Trading Up 3.7%

IRMD stock traded up $2.65 during trading hours on Thursday, hitting $73.41. 16,972 shares of the stock traded hands, compared to its average volume of 44,135. The stock has a 50-day simple moving average of $66.79 and a 200 day simple moving average of $58.81. iRadimed Corporation has a one year low of $46.86 and a one year high of $74.43. The company has a market cap of $933.78 million, a P/E ratio of 45.31 and a beta of 1.02.

iRadimed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Monday, August 18th were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.68 annualized dividend and a yield of 0.9%. iRadimed's dividend payout ratio (DPR) is currently 41.98%.

iRadimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.